Rare diseases
Investigational molecules
Locations
Comparing lenalidomide and methotrexate for patients with difficult-to-treat cutaneous lupus erythematosus
FranceA Study of BNT323 and BNT327 for Patients with Advanced Breast Cancer to Test Safety and Effectiveness
FranceA Study to Test the Safety and Effectiveness of TAK-360 in People with Narcolepsy without Cataplexy
FranceA Study of Zanidatamab for Patients with Previously Treated HER2-Expressing Solid Tumors
FranceA study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation
FranceA Study of LAD191 Compared to Placebo and Adalimumab in Adults with Moderate-to-Severe Hidradenitis Suppurativa
FranceA Study Testing AOC 1020 to Improve Movement in Adults with Facioscapulohumeral Muscular Dystrophy
FranceStudy of xaluritamig plus abiraterone for men with metastatic castration-resistant prostate cancer who have not received chemotherapy
FranceA Study of Repinatrabit Compared to Placebo for Treatment of Patients with Phenylketonuria
FranceA Study Testing Anti-CD19 CAR T-Cell Therapy in Patients with Systemic Sclerosis Who Did Not Respond to Immunosuppressive Drugs
FranceA study comparing erdafitinib delivery system to chemotherapy for patients with high-risk non-muscle-invasive bladder cancer who received BCG treatment
FranceVorasidenib for patients with IDH-mutant grade 2 or 3 astrocytoma after completing first-line chemoradiotherapy
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
